Cognitive Dysfunction in Non-CNS Metastatic Cancer: Comparing Brain Metastasis, Non-CNS Metastasis, and Healthy Controls

References

• Mariotto AB, Etzioni R, Hurlbert M, Penberthy L, Mayer M. Estimation of the number of women living with metastatic breast cancer in the United States. Cancer. Cancer Epidemiol Biomarkers Prev. 2017;26(6):809–815. doi:10.1158/1055-9965.EPI-16-0889.
   PubMed Web of Science ®Google Scholar
• Miller KD, Weathers T, Haney L, Timmerman R, Dickler M, Shen J, et al. Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival. Ann Oncol. 2003;14(7):1072–1077. doi:10.1093/annonc/mdg300.
   PubMed Web of Science ®Google Scholar
• Nayak L, Lee EQ, Wen PY. Epidemiology of brain metastases. Curr Oncol Rep. 2012;14(1):48–54. doi:10.1007/s11912-011-0203-y.
   PubMed Web of Science ®Google Scholar
• Lin X, DeAngelis LM. Treatment of brain metastases. J Clin Oncol. 2015;33(30):3475–3484. doi:10.1200/JCO.2015.60.9503.
   PubMed Web of Science ®Google Scholar
• Guan X. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 2015;5(5):402–418. doi:10.1016/j.apsb.2015.07.005.
   PubMed Web of Science ®Google Scholar
• Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004;22(1):157–165. doi:10.1200/JCO.2004.05.128.
   PubMed Web of Science ®Google Scholar
• Dwan TM, Ownsworth T, Chambers S, Walker DG, Shum DH. Neuropsychological assessment of individuals with brain tumor: comparison of approaches used in the classification of impairment. Front Oncol. 2015;5:56. doi:10.3389/fonc.2015.00056.
   PubMed Web of Science ®Google Scholar
• Gerstenecker A, Nabors LB, Meneses K, Fiveash JB, Marson DC, Cutter G, et al. Cognition in patients with newly diagnosed brain metastasis: profiles and implications. J Neurooncol. 2014;120(1):179–185. doi:10.1007/s11060-014-1543-x.
   PubMed Web of Science ®Google Scholar
• Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):1037–1044. doi:10.1016/S1470-2045(09)70263-3.
   PubMed Web of Science ®Google Scholar
• Chang EL, Wefel JS, Maor MH, Hassenbusch IIS, Mahajan A, Lang FF, et al. A pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery. 2007;60(2):277–284. doi:10.1227/01.NEU.0000249272.64439.B1.
   PubMed Web of Science ®Google Scholar
• Herman MA, Tremont-Lukats I, Meyers CA, Trask DD, Froseth C, Renschler MF, et al. Neurocognitive and functional assessment of patients with brain metastases: a pilot study. Am J Clin Oncol. 2003;26(3):273–279. doi:10.1097/01.COC.0000020585.85901.7C.
   PubMed Web of Science ®Google Scholar
• Cordes MC, Scherwath A, Ahmad T, Cole AM, Ernst G, Oppitz K, et al. Distress, anxiety and depression in patients with brain metastases before and after radiotherapy. BMC Cancer. 2014;14(1):731. doi:10.1186/1471-2407-14-731.
   PubMedGoogle Scholar
• Khuntia D, Mathew B, Meyers C, Johnson S, Mehta M. Brain metastases. Cognition and cancer. Cambridge: CambridgeUniversityPress;.2008. p. 170–186.
   Google Scholar
• Marotta D, Tucker Z, Hayward EN, Gerstenecker A, Gammon M, Mason M, et al. Relationship between cognitive functioning, mood, and other patient factors on quality of life in metastatic brain cancer. Psychooncology. 2020;29(7):1174–1184. doi:10.1002/pon.5401.
   PubMedGoogle Scholar
• Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer. 2011;19(10):1647–1656. doi:10.1007/s00520-010-0997-4.
   PubMed Web of Science ®Google Scholar
• Olson B, Marks DL. Pretreatment cancer-related cognitive impairment—mechanisms and outlook. Cancers (Basel)). 2019;11(5):687. doi:10.3390/cancers11050687.
   PubMed Web of Science ®Google Scholar
• Noll KR, Bradshaw ME, Parsons MW, Dawson EL, Rexer J, Wefel JS. Monitoring of neurocognitive function in the care of patients with brain tumors. Curr Treat Options Neurol. 2019;21(7):33. doi:10.1007/s11940-019-0573-2.
   PubMedGoogle Scholar
• Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100(11):2292–2299. doi:10.1002/cncr.20272.
   PubMed Web of Science ®Google Scholar
• Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014;26(1):102–113. doi:10.3109/09540261.2013.864260.
   PubMed Web of Science ®Google Scholar
• Ahles TA, Root JC, Ryan EL. Cancer-and cancer treatment–associated cognitive change: an update on the state of the science. J Clin Oncol. 2012;30(30):3675–3686. doi:10.1200/JCO.2012.43.0116.
   PubMed Web of Science ®Google Scholar
• Vannorsdall TD. Cognitive changes related to cancer therapy. Med Clin North Am. 2017;101(6):1115–1134. doi:10.1016/j.mcna.2017.06.006.
   PubMed Web of Science ®Google Scholar
• Vardy J, Dhillon H, Pond G, Rourke S, Xu W, Dodd A, et al. Cognitive function and fatigue after diagnosis of colorectal cancer. Ann Oncol. 2014;25(12):2404–2412. doi:10.1093/annonc/mdu448.
   PubMed Web of Science ®Google Scholar
• Triebel KL, Gerstenecker A, Meneses K, Fiveash JB, Meyers CA, Cutter G, et al. Capacity of patients with brain metastases to make treatment decisions. Psychooncology. 2015;24(11):1448–1455. doi:10.1002/pon.3753.
   PubMed Web of Science ®Google Scholar
• Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47(2):291–298. doi:10.1016/s0360-3016(99)00507-6.
   PubMed Web of Science ®Google Scholar
• Brandt J, Benedict RH. Hopkins verbal learning test–revised: professional manual. Lutz (FL): PAR, Inc.; 2001.
   Google Scholar
• Wechsler D. Wechsler adult intelligence scale. Administration and scoring manual. 3rd ed. San Antonio (TX): The Psychological Corporation; 1997.
   Google Scholar
• Ruff R, Light R, Parker S, Levin H. Benton controlled oral word association test: reliability and updated norms. Arch Clin Neuropsychol. 1996;11(4):329–338. doi:10.1093/arclin/11.4.329.
   PubMed Web of Science ®Google Scholar
• Reitan R, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Vol. 4. Berlin, Germany: Springer;.1985.
   Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi:10.1111/j.1600-0447.1983.tb09716.x.
   PubMed Web of Science ®Google Scholar
• Beck AS, Brown GK. BDI-II Manual. New YorK: Pearson Inc.;1996.
   Google Scholar
• Karnofsky DA. The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of chemotherapeutic agents. New York, NY: ColumbiaUniversityPress.; 1949. p. 191–205.
   Google Scholar
• Ferguson CJ. An effect size primer: a guide for clinicians and researchers. In: Kazdin AE, editor. Methodological issues and strategies in clinical research. 4th ed. American Psychological Association; 2016. p. 301–310. doi:10.1037/14805-020.
   Google Scholar
• Aita SL, Moncrief GG, Greene J, Trujillo S, Carrillo A, Iwanicki S, et al. Univariate and multivariate base rates of score elevations, reliable change, and inter-rater discrepancies in the BRIEF-A standardization samples. Assessment. 2021;30(2):390–401. doi:10.1177/10731911211055673.
   PubMedGoogle Scholar
• Meyers CA. Neurocognitive dysfunction in cancer patients. Oncology (Williston Park). 2000;14(1):75–79.
   PubMedGoogle Scholar
• Noh T, Walbert T. Brain metastasis: clinical manifestations, symptom management, and palliative care. Handb Clin Neurol. 2018;149:75–88. doi:10.1016/B978-0-12-811161-1.00006-2.
   PubMedGoogle Scholar
• Wefel JS, Witgert ME, Meyers CA. Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev. 2008;18(2):121–131. doi:10.1007/s11065-008-9058-x.
   PubMed Web of Science ®Google Scholar
• Joly F, Heutte N, Duclos B, Noal S, Léger-Hardy I, Dauchy S, et al. Prospective evaluation of the impact of antiangiogenic treatment on cognitive functions in metastatic renal cancer. Eur Urol Focus. 2016;2(6):642–649. doi:10.1016/j.euf.2016.04.009.
   PubMedGoogle Scholar
• Oltra-Cucarella J, Sánchez-SanSegundo M, Rubio-Aparicio M, Arango-Lasprilla JC, Ferrer-Cascales R. The association between the number of neuropsychological measures and the base rate of low scores. Assessment. 2021;28(3):955–963. doi:10.1177/1073191119864646.
   PubMed Web of Science ®Google Scholar
• Darki F, Klingberg T. The role of fronto-parietal and fronto-striatal networks in the development of working memory: a longitudinal study. Cereb Cortex. 2015;25(6):1587–1595. doi:10.1093/cercor/bht352.
   PubMed Web of Science ®Google Scholar
• Liston C, Watts R, Tottenham N, Davidson MC, Niogi S, Ulug AM, et al. Frontostriatal microstructure modulates efficient recruitment of cognitive control. Cereb Cortex. 2006;16(4):553–560. doi:10.1093/cercor/bhj003.
   PubMedGoogle Scholar
• Ullsperger M, von Cramon DY. The role of intact frontostriatal circuits in error processing. J Cogn Neurosci. 2006;18(4):651–664. doi:10.1162/jocn.2006.18.4.651.
   PubMed Web of Science ®Google Scholar
• Cimprich B, Reuter-Lorenz P, Nelson J, Clark PM, Therrien B, Normolle D, et al. Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol. 2010;32(3):324–331. doi:10.1080/13803390903032537.
   PubMed Web of Science ®Google Scholar
• Scherling C, Collins B, MacKenzie J, Bielajew C, Smith A. Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study. Front Hum Neurosci. 2011;5:122. doi:10.3389/fnhum.2011.00122.
   PubMed Web of Science ®Google Scholar
• López Zunini RA, Scherling C, Wallis N, Collins B, MacKenzie J, Bielajew C, et al. Differences in verbal memory retrieval in breast cancer chemotherapy patients compared to healthy controls: a prospective fMRI study. Brain Imaging Behav. 2013;7(4):460–477. doi:10.1007/s11682-012-9213-0.
   PubMedGoogle Scholar
• Menning S, de Ruiter MB, Veltman DJ, Koppelmans V, Kirschbaum C, Boogerd W, et al. Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment—the role of fatigue. Neuroimage Clin. 2015;7:547–554. doi:10.1016/j.nicl.2015.02.005.
   PubMed Web of Science ®Google Scholar
• Scherling C, Collins B, MacKenzie J, Bielajew C, Smith A. Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: a functional magnetic resonance imaging study. J Clin Exp Neuropsychol. 2012;34(5):543–560. doi:10.1080/13803395.2012.666227.
   PubMed Web of Science ®Google Scholar
• Gerstenecker A, Gammon M, Marotta D, Fiveash J, Nabors B, Mulhauser K, et al. Using cognition to predict the ability to understand medical treatment in brain and metastatic cancer. Psychooncology. 2020;29(2):406–412. doi:10.1002/pon.5277.
   PubMedGoogle Scholar
• Mulhauser K, Marotta DA, Gerstenecker A, Wilhelm G, Myers T, Gammon M, et al. Capacity to consent to research participation in adults with metastatic cancer: comparisons of brain metastasis, non-CNS metastasis, and healthy controls. Neurooncol Pract. 2020;7(4):439–445. doi:10.1093/nop/npaa008.
   PubMed Web of Science ®Google Scholar
• Etters L, Goodall D, Harrison BE. Caregiver burden among dementia patient caregivers: a review of the literature. J Am Acad Nurse Pract. 2008;20(8):423–428. doi:10.1111/j.1745-7599.2008.00342.x.
   PubMed Web of Science ®Google Scholar